jag009
★★★

NJ,
2018-09-07 18:31
(912 d 04:56 ago)

Posting: # 19251
Views: 1,606
 

 FDA Supac guidance for ER [Regulatives / Guidelines]

Hi,

Question. To support SUPAC (post approval manufacturing site change) filing for ER products, do we need to perform multimedia dissolution testings?

Thanks
John
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2018-09-09 12:04
(910 d 11:23 ago)

@ jag009
Posting: # 19253
Views: 1,340
 

 FDA Supac guidance for ER

Hi John,

» To support SUPAC (post approval manufacturing site change) filing for ER products, do we need to perform multimedia dissolution testings?

Generally not. That’s a Level 3 Change.
See the guidance V. C. 2. b. Dissolution documentation:

In addition to application/compendial release requirements, a multipoint dissolution profile should be obtained using application/compendial test conditions for the changed drug product and the biobatch or marketed batch (unchanged drug product). Adequate sampling should be performed, for example at 1, 2, and 4 hours and every two hours thereafter until either 80% of the drug from the drug product is released or an asymptote is reached.

But don’t forget V. C. 2. c. Bioequivalence documentation:

A single-dose bioequivalence study. The bioequivalence study may be waived in the presence of an established in vitro/in vivo correlation.


Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
jag009
★★★

NJ,
2018-09-10 16:38
(909 d 06:50 ago)

@ Helmut
Posting: # 19256
Views: 1,301
 

 FDA Supac guidance for ER

Thank Helmut!
Activity
 Admin contact
21,371 posts in 4,463 threads, 1,496 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time: Sunday 23:28 UTC (Europe/Vienna)

When puzzled, it never hurts to read the primary documents 
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5